Peder Sven Walberg
Director/Board Member at EGETIS THERAPEUTICS AB
Net worth: 21 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yilmaz Mahshid | M | 45 | 7 years | |
| Mats Blom | M | 59 | 3 years | |
| Thomas Lönngren | M | 73 | 3 years | |
| Nicklas Westerholm | M | 48 | 7 years | |
| Laetitia Szaller | F | - | 1 years | |
| Lena Elisabeth Svanberg | M | 63 | 7 years | |
| Thomas Lennart Eklund | M | 57 |
Immedica Pharma Holding AB
Immedica Pharma AB
 Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | - |
| Karl Hård | M | 62 | 2 years | |
| Gunilla Christina Osswald | M | 63 | 7 years | |
| Anna Sjögren | F | 56 |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | 5 years |
| Nils Hallén | M | 56 | 1 years | |
| Stefan Larsson | M | - |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | 3 years |
| Christine Wesström | F | 49 | 14 years | |
| Marianne Berrens-Peijnenburg | M | - | 2 years | |
| Kristina Nygren | - | - | 3 years | |
| Christian Sonesson | M | 49 | 7 years | |
| Peter Verwaijen | M | - | 2 years | |
| Malin Nittve | F | 61 | - | |
| Fredrik Holmström | M | 53 |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | - |
| Kerstin Valinder-Strinnholm | F | 64 |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | 4 years |
| Katayoun Welin-Berger | M | 56 | 1 years | |
| Linda Armstrong | M | 61 | 17 years | |
| Magnus Edlund | M | - |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | 6 years |
| Henrik Krook | M | 51 | 4 years | |
| Marie Bengtson | F | - | 13 years | |
| Anders Edvell | M | 55 |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | 6 years |
| Lisa Bright | F | 56 |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jacques Näsström | M | 65 | 13 years | |
| Joseph Jimenez | M | 64 | 11 years | |
| Andreas von Planta | M | 68 | - | |
| Alf Gunnar Martin Nicklasson | M | 69 | 3 years | |
| Bali Muralidhar | M | 44 | 4 years | |
| Genghis Lloyd-Harris | M | 67 | - | |
| Dina Chaya | M | 52 | 3 years | |
| Erling Lennart Johansson | M | 69 | - | |
| Thomas Wellauer | M | 69 | - | |
| Adine Charlotte Grate Axén | F | 63 | - | |
| Mun Tak Yang | F | 70 | - | |
| Marie Ekstrom Tragardh | F | 63 | 3 years | |
| Juan Andres | M | 59 | 12 years | |
| Alexandre Grassin | M | 46 | 3 years | |
| Karim Hanna | M | - | 5 years | |
| Stefan Blarer | M | - | 10 years | |
| Steven Baert | M | 50 | 15 years | |
| Udit Batra | M | 53 | 2 years | |
| Beth Calitri | F | - | 8 years | |
| Martin G. Friedman | M | - | 1 years | |
| Georges Gemayel | M | 64 |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | - |
| Thomas Plitz | M | 56 | - | |
| Jeanette Wood | M | 72 | 26 years | |
| Jonathan Peacock | M | 66 | 5 years | |
| Armand Sohet | M | 59 | 1 years | |
| Emmanuel Dulac | M | 55 | 8 years | |
| Petra Tesch | F | 61 | 5 years | |
| Stefan Carlsson | M | 64 | 4 years | |
| Lars Sandström | M | 52 | 2 years | |
| Marie-Louise Alamaa | F | - | - | |
| Rafael Torgovicky | M | - | 1 years | |
| Mikael Carlsson | M | 59 | 1 years | |
| Helene Depui Ekdal | F | 56 | - | |
| Mc Callion Orla | M | - |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | 9 years |
| Jeffrey George | M | 51 | - | |
| Meenu Chhabra Karson | F | 51 | 1 years | |
| John Martin Manser | M | 77 | 11 years | |
| Khalid Islam | M | 67 |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | 3 years |
| Pierre F. Dodion | M | 69 | 4 years | |
| Susan M. Flint | F | 73 | 5 years | |
| Karen Hübscher | M | 61 | 6 years | |
| Paul Choffat | M | - | 5 years | |
| Thomas Ebeling | M | 65 | 7 years | |
| Thomas Werlen | M | - | 5 years | |
| Erika Kjellberg-Eriksson | F | 62 |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | 3 years |
| Bo Jesper Hansen | M | 66 | 6 years | |
| Håkan Åström | M | 77 | 9 years | |
| Stig Lennart Hansson | M | 68 |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | - |
| Andreas Rummelt | M | 66 | 4 years | |
| David J. Clark | M | 59 | 2 years | |
| Steven Kelmar | M | 70 | 4 years | |
| Rémi Droller | M | 48 |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | - |
| Guy Rousseau | M | - | 6 years | |
| Charl van Zyl | M | 57 | 3 years | |
| Mats-Olof Ljungquist | M | 72 | 3 years | |
| Leone Patterson | F | 61 | 1 years | |
| Mason W. Freeman | M | 73 | 2 years | |
| Erik Kinnman | M | 66 | 3 years | |
| Monika Matti | F | - | - | |
| Peter Sellei | M | 64 | 1 years | |
| Seth Brodsky | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 54 | 61.36% |
| Switzerland | 34 | 38.64% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peder Sven Walberg
- Personal Network
